We publish no single base value for Hubbell Incorporated. Our valuation methods put it between $471.41 and $588.75 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate.
| Method | Value | vs price | Basis |
|---|---|---|---|
| Discounted cash flow | $588.75 | +34.4% | free cash flow $928.00m, growth 15.96% for 5 years, then fading to 3% over 5 more, discounted at 9.54%; stress floor $279.00 |
| Exit multiple (P/E) | $471.41 | +7.6% | earnings per share $20.59 valued at 22.29× (the stock's own median P/E) in 5 years, discounted back |
| Sum of the parts | — | — | no sum of the parts: this run holds no segment disclosure for the name |
| Price to sales | — | — | not reached: the cash-flow or earnings methods produced an anchor, so this fallback was not run |
| Tangible book | — | — | used only for lenders, where book value is the business |
| Price to FFO (REITs) | — | — | used only for REITs |
Each working is rebuilt by code from the valuation's own figures and checked against the published value.
The discount rate:
| Risk-free rate | 5.13% (10-year US Treasury yield) |
| Company's own beta | 0.84 (5 years of monthly returns against the S&P 500; standard error 0.21) |
| Peer beta | 1.00 (median of 13 S&P 500 Industrial Machinery & Supplies & Components companies) |
| Blend of own and peers | 0.97 (23% own, 77% peers, weighted by how precisely the company's own beta is measured) |
| Adjusted beta | 0.98 (0.67 × 0.97 + 0.33, pulled toward the market's 1.0) |
| Equity risk premium | 4.5% |
| Discount rate = risk-free + adjusted beta × premium | 9.54% |
Free cash flow grows 15.96% a year for 5 years, then fades in equal steps toward 3% over 5 more; each year is discounted by 1 ÷ (1 + rate)^year:
| Year | Growth | Free cash flow | Discount factor | Present value |
|---|---|---|---|---|
| Now | — | $928.00m | — | — |
| Year 1 | 15.96% | $1.08bn | 0.9129 | $982.39m |
| Year 2 | 15.96% | $1.25bn | 0.8334 | $1.04bn |
| Year 3 | 15.96% | $1.45bn | 0.7608 | $1.10bn |
| Year 4 | 15.96% | $1.68bn | 0.6946 | $1.17bn |
| Year 5 | 15.96% | $1.95bn | 0.6341 | $1.23bn |
| Year 6 | 13.80% | $2.21bn | 0.5788 | $1.28bn |
| Year 7 | 11.64% | $2.47bn | 0.5284 | $1.31bn |
| Year 8 | 9.48% | $2.71bn | 0.4824 | $1.31bn |
| Year 9 | 7.32% | $2.90bn | 0.4404 | $1.28bn |
| Year 10 | 5.16% | $3.05bn | 0.4020 | $1.23bn |
| Terminal value = year-10 cash flow × (1 + 3%) ÷ (9.54% − 3%) | $48.10bn |
| Terminal value in today's money | $19.34bn |
| Present value of years 1–10 | $11.92bn |
| Total present value | $31.26bn |
| Shares outstanding | 53.10m |
| Value per share = total ÷ shares | $588.75 |
How the DCF value moves with the discount rate and the starting growth (the middle cell is the published value):
| Discount rate | Growth 10.96% | Growth 15.96% | Growth 20.96% |
|---|---|---|---|
| 8.54% | $526.38 | $707.98 | $946.59 |
| 9.54% | — | $588.75 | $782.97 |
| 10.54% | — | $501.69 | $663.69 |
The same DCF at each beta, starting growth unchanged:
| Beta | Value | Discount rate | DCF value |
|---|---|---|---|
| Company's own beta | 0.84 | 8.91% | $659.08 |
| Peer beta | 1.00 | 9.63% | $579.82 |
| Adjusted beta (used) | 0.98 | 9.54% | $588.75 |
Earnings per share grow on the same fading path as the DCF:
| Year | Growth | Earnings per share |
|---|---|---|
| Now | — | $20.59 |
| Year 1 | 15.96% | $23.87 |
| Year 2 | 12.07% | $26.75 |
| Year 3 | 9.35% | $29.26 |
| Year 4 | 7.45% | $31.43 |
| Year 5 | 6.11% | $33.35 |
| Earnings per share in year 5 | $33.35 |
| Exit P/E (the stock's own median P/E) | 22.29× |
| Value in 5 years = earnings × P/E | $743.48 |
| Discounted at 9.54% over 5 years: ÷ 1.5771 | $471.41 |
We publish no single base value for Hubbell Incorporated. Our valuation methods put it between $471.41 and $588.75 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate.
One-year price simulation: a 10% chance the price is below $309.51 and a 10% chance it is above $679.78 in a year; a 56% chance it is higher than today's $437.98, from 30.54% volatility. The simulation assumes the price drifts up at our discount rate of 9.54% a year.
At $437.98 the price implies free cash flow growing 10.9% a year for five years and then fading toward 3% over five more; its revenue has grown 16.0%.
| Week | Price | Base value |
|---|---|---|
| 2 Oct 2026 | $475.52 | — |
| 9 Oct 2026 | $474.11 | — |
| 16 Oct 2026 | $461.10 | $411.29 |
| 23 Oct 2026 | $448.10 | $412.90 |
| 30 Oct 2026 | $422.44 | — |
| 6 Nov 2026 | $429.45 | — |
| 12 Nov 2026 | $437.98 | — |
Data as of 12 Nov 2026; financials to 30 Sep 2026. Sources: company filings via EODHD, SEC EDGAR, US Treasury. How these values are computed. Not investment advice.
Run a full Desk Run on HUBB · Hubbell Incorporated company page · Call and put prices